Amarin Corp. (AMRN) Debuts Smaller Vascepa Capsules

October 25, 2016 7:38 AM EDT

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

Amarin Corporation plc (Nasdaq: AMRN) announced the introduction of a smaller 0.5-gram capsule size for Vascepa (icosapent ethyl) available now in retail pharmacies nationwide. The smaller capsule is in addition to the original and currently available 1-gram size Vascepa capsule.

The FDA-approved dosing for Vascepa continues to be four grams per day, taken as two grams twice daily, with food. Based on market research with healthcare providers, Amarin believes that the majority of patients taking Vascepa will continue to be prescribed the 1-gram size Vascepa capsule.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News

Add Your Comment